Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use onl...

FDA Drug Recall #D-0671-2026 - Class II, June 24, 2026

Recall Summary

Recall Number D-0671-2026
Classification Class II - Moderate risk
Date Initiated June 24, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Reliance Life Sciences Private Limited
Location Navi Mumbai, N/A
Product Type Drugs
Quantity 12,000 vials

Product Description

Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01

Reason for Recall

Lack of Sterility Assurance

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lot, expiry: RPTL0325A Dec 31, 2027; RPTL0425A Dec 31, 2027; RPTL0624B Nov 30,2027; RPTL0625A Mar 31, 2028

Other Recalls from Reliance Life Sciences Private Limited

Recall # Classification Product Date
D-0672-2026 Class II Pemetrexed for Injection 500mg/Vial, 1 50 mL Si... Jun 24, 2026
D-0673-2026 Class II Bortezomib for Injection 3.5mg/Vial, 10 mL per ... Jun 24, 2026
D-0674-2026 Class II Azacitidine for Injection 100mg/Vial, 1 10 mL S... Jun 24, 2026

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections, all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.